Abbott Reopens Its Michigan Plant Closed Due To Floods: Report
Abbott Laboratories (NYSE:ABT) has reopened its Sturgis, Michigan, baby formula plant, which was shut last month due to heavy…
Patient Death Prompts MacroGenics To Close Mid-Stage Head & Cancer Study
MacroGenics Inc (NASDAQ:MGNX) closed the Phase 2 study (CP-MGA271-06) of enoblituzumab in the first-line treatment of patients with recurrent or metastatic…
Raymond James Initiates Coverage On This Stock With Bullish Pitch On Gene Therapies
Raymond James initiated coverage on Rocket Pharmaceuticals Inc (NASDAQ: RCKT) with an Outperform rating with a $22 price target based on the positive view of RP-L102 and RP-L201 gene therapy programs and LAD-I.
Needham Cuts Price Target On This NASH-Focused Stock As Its Awaits Visibility On Regulatory Path
Yesterday, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced data from the new interim analysis of the Phase 3 REGENERATE trial evaluating obeticholic acid in…
Why This Small-Cap Stock Is Gaining More Than 10% Today?
Chardan has initiated coverage of Immuneering Corp (NASDAQ:IMRX) with a Buy rating and a price target of $18. Immuneering’s lead candidate, IMM-1-104, an…
AbbVie Dumps An Early-Alzheimer’s Candidate Developing In Collaboration With Alector
AbbVie Inc (NYSE:ABBV) has decided to terminate the CD33 collaboration program with Alector Inc (NASDAQ:ALEC), developing AL003 for Alzheimer’s disease as one of…
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
Here's a roundup of top developments in the biotech space over the last 24 hours:
ADC Therapeutics, Sobi Ink European Licensing Pact For Lymphoma Drug
ADC Therapeutics SA (NYSE:ADCT) has entered into an exclusive license agreement with Swedish Orphan Biovitrum AB (OTC:BIOVF) for the development and commercialization of…
RVL Pharma Issues Interim Q2 Sales From Its Droopy Eye Treatment
RVL Pharmaceuticals plc (NASDAQ:RVLP) announced preliminary Q2 FY22 sales from Upneeq of $8.4 million, up 42% sequentially. Upneeq (oxymetazoline hydrochloride…
Inotiv Expands Protein/Peptide Bioanalytical Capabilities With This Deal
Contract research organization Inotiv Inc (NASDAQ:NOTV) acquired Nashville, Tennessee-based Protypia Inc for $11 million. Inotiv specializes in nonclinical and analytical drug discovery,…